Agneta Siegbahn
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management 21
-
- Acute Myocardial Infarction Research 37
- Atrial Fibrillation Management and Outcomes 31
- Antiplatelet Therapy and Cardiovascular Diseases 18
- Heart Failure Treatment and Management 13
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 17
- Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms 34
- Immunology top 1%
-
- GDF15 and Related Biomarkers 13
- Co-authors
- Lars WallentinCarl‐Henrik HeldinBertil LindahlLena Claesson‐WelshPer VengeHenrik TossJohannes WaltenbergerMasabumi Shibuya
- Journals
- Journal of the American College of Cardiology (17 papers)Thrombosis Research (15 papers)Thrombosis and Haemostasis (12 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Agneta Siegbahn
190 papers receiving 13.6k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Internal Medicine 1.6k
- Cardiology and Cardiovascular Medicine 5.9k
- Immunology and Allergy 903
- Hematology 1.2k
- Immunology 2.2k
Countries citing papers authored by Agneta Siegbahn
This map shows the geographic impact of Agneta Siegbahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Siegbahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Siegbahn more than expected).
Fields of papers citing papers by Agneta Siegbahn
This network shows the impact of papers produced by Agneta Siegbahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Siegbahn. The network helps show where Agneta Siegbahn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Agneta Siegbahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 23 | |
| 2 | 2019 | 15 | |
| 3 | 2017 | 133 | |
| 4 | 2016 | 10 | |
| 5 | 2015 | 110 | |
| 6 | Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation : Insights from the ARISTOTLE trial | 2015 | 7 |
| 7 | 2015 | 1 | |
| 8 | Interleukin-6 and C-reactive protein and risk for cardiovascular events and death in anticoagulated patients with atrial fibrillation | 2014 | 1 |
| 9 | 2013 | 111 | |
| 10 | 2012 | 304 | |
| 11 | Abstract 15929: Outcomes with Ticagrelor Versus Clopidogrel in Relation to High Sensitivity Troponin-T in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with Early Invasive or Non-Invasive Treatment - A Substudy from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial | 2012 | 3 |
| 12 | 2009 | 98 | |
| 13 | 2008 | 172 | |
| 14 | 2005 | 57 | |
| 15 | 2004 | 34 | |
| 16 | 2004 | 1 | |
| 17 | 1998 | 34 | |
| 18 | 1997 | 104 | |
| 19 | 1997 | 260 | |
| 20 | 1992 | 223 |
About Agneta Siegbahn
Agneta Siegbahn is a scholar working on Internal Medicine, Hematology, Cardiology and Cardiovascular Medicine, Immunology and Allergy and Immunology, having authored 191 papers that have together received 14.0k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (37 papers), Blood Coagulation and Thrombosis Mechanisms (34 papers), Atrial Fibrillation Management and Outcomes (31 papers), Venous Thromboembolism Diagnosis and Management (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Cell Adhesion Molecules Research (17 papers), Heart Failure Treatment and Management (13 papers) and GDF15 and Related Biomarkers (13 papers). The work is most often cited by research in Internal Medicine (1.6k citations), Cardiology and Cardiovascular Medicine (5.9k citations), Immunology and Allergy (903 citations), Hematology (1.2k citations) and Immunology (2.2k citations). Agneta Siegbahn has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Lars Wallentin, Carl‐Henrik Heldin, Bertil Lindahl, Lena Claesson‐Welsh, Per Venge, Henrik Toss, Johannes Waltenberger, Masabumi Shibuya, Jonas Oldgren and Eva Lindmark. Their work appears in journals such as Journal of the American College of Cardiology, Thrombosis Research, Thrombosis and Haemostasis, Arteriosclerosis Thrombosis and Vascular Biology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.